Raja Kumaraguru
Stock Analyst at Roth MKM
(0)
# 5285
Out of 5,332 analysts
6
Total ratings
0.00%
Success rate
-74.40%
Average return
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
RAIN Rain Oncology | Downgrades: Neutral | 2 | 4.86 | -75.31% | 1 | May 30, 2023 | |
NLSP NLS Pharmaceutics | Initiates Coverage On: Buy | 480 | 1.69 | 28302.37% | 1 | Mar 12, 2021 | |
CLBS Caladrius Bioscience... | Maintains: Buy | 70 100 | n/a | n/a | 1 | Mar 3, 2021 | |
CNSP CNS Pharma | Initiates Coverage On: Buy | 750000 | n/a | n/a | 1 | Feb 2, 2021 | |
FBRX Forte Biosciences | Initiates Coverage On: Buy | 2250 | 6.17 | 36366.77% | 1 | Aug 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 210 | 39.5 | 431.65% | 1 | Feb 19, 2020 |